Jaguar Health (JAGX) Other Operating Expenses (2015 - 2026)
Jaguar Health's (JAGX) quarterly Other Operating Expenses came in at $5.1 million in Q1 2026, up 19.81% year-on-year from $4.2 million in Q1 2025, and down 3.64% on a QoQ basis from $5.3 million in Q4 2025.
Jaguar Health (JAGX) Other Operating Expenses (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Other Operating Expenses data on file, last reported at $5.1 million in Q1 2026.
- On a quarterly basis, Other Operating Expenses rose 19.81% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $15.9 million, a 30.92% decrease from a year earlier, with the FY2025 full-year figure at $13.8 million, down 25.34% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $5.1 million, down from $5.3 million in the prior quarter.
- Over the last five years, Other Operating Expenses for JAGX reached as high as $14.7 million in Q4 2023 and fell as low as $1.9 million in Q1 2024.
- Historically, Other Operating Expenses has averaged $4.7 million across 5 years, with a median of $3.3 million in 2022.
- Across the five-year window, Other Operating Expenses jumped 1058.55% in 2022 and plunged 69.69% in 2023, its largest moves.
- Year by year, Other Operating Expenses stood at $2.2 million in 2022, then surged by 556.49% to $14.7 million in 2023, then decreased by 17.68% to $12.1 million in 2024, then plunged by 56.46% to $5.3 million in 2025, then retreated by 3.64% to $5.1 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $5.1 million in Q1 2026, $5.3 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.37 Bn | 468.58 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.58 Bn | 116.33 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.54 Bn | 62.78 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.17 Bn | 62.17 Bn | - |
| 7 | Argenx Se | 54.63 Bn | 49.44 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.11 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.17 Bn | 36.17 Bn | - |
| 10 | Jaguar Health | 523,524.81 | -9.54 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.09 Mn |
| Dec 31, 2025 | 5.28 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 2.99 Mn |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 12.12 Mn |
| Sep 30, 2024 | 2.55 Mn |
| Jun 30, 2024 | 4.08 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 14.73 Mn |
| Sep 30, 2023 | 1.99 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Mar 31, 2023 | 2.23 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Sep 30, 2022 | 6.55 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 3.29 Mn |
| Dec 31, 2021 | -234,000.00 |
| Sep 30, 2021 | 3.93 Mn |
| Jun 30, 2021 | 3.03 Mn |